Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.72 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.64 |
| ▸ | GSK3B | P49841 | 5/20 | 0.57 |
| ▸ | GSK3A | P49840 | 4/20 | 0.57 |
| ▸ | RHOA | P61586 | 1/20 | 0.57 |
| ▸ | HDAC3 | O15379 | 5/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.55 |
| ▸ | HDAC2 | Q92769 | 5/20 | 0.55 |
| ▸ | AURKA | O14965 | 4/20 | 0.54 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.54 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.53 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.50 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.50 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.50 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.48 |
| ▸ | CDC7 | O00311 | 1/20 | 0.48 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30923165 | 0.86 | HDAC6 (0.55) | HDAC6HCAR3GSK3BGSK3AHDAC3 | |
| SCHEMBL2497628 | 0.86 | HDAC6 (0.55) | HDAC6HCAR3GSK3BGSK3AHDAC3 | |
| SCHEMBL4487993 | 0.85 | HDAC6 (0.68) | HDAC6HCAR3GSK3BGSK3ARHOA | |
| SCHEMBL30923086 | 0.85 | CAMK2D (0.56) | HDAC6HCAR3GSK3BGSK3AHDAC3 | |
| SCHEMBL3698385 | 0.84 | HDAC6 (1.00) | HDAC6HDAC3HDAC1HDAC2 | |
| SCHEMBL31141640 | 0.82 | HDAC6 (0.73) | HDAC6HCAR3GSK3BGSK3AHDAC3 | |
| SCHEMBL3634270 | 0.80 | HDAC3 (0.74) | HDAC6HDAC3HDAC1HDAC2AURKA | |
| SCHEMBL12190155 | 0.79 | HDAC6 (0.64) | HDAC6AURKA | |
| SCHEMBL30923190 | 0.79 | HCAR3 (0.53) | HDAC6HCAR3AURKB | |
| SCHEMBL18713280 | 0.79 | HDAC6 (0.68) | HDAC6HCAR3GSK3BGSK3AHDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113463148-A | Method for electroplating gold on surface of titanium or titanium alloy substrate | 惠州市安泰普表面处理科技有限公司 | 2021-10-01 | — | — | CN | claimed |
| JP-3127790-A | — | — | None | — | — | JP | disclosed |
| CN-113463148-A | Method for electroplating gold on surface of titanium or titanium alloy substrate | 惠州市安泰普表面处理科技有限公司 | 2021-10-01 | — | — | CN | disclosed |
| CN-113463148-A | Method for electroplating gold on surface of titanium or titanium alloy substrate | 惠州市安泰普表面处理科技有限公司 | 2021-10-01 | — | — | CN | disclosed |
| WO-2012024179-A1 | SUBSTITUTED AMIDE DERIVATIVES AS DGAT-1 INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2012-02-23 | — | — | WO | disclosed |
| CN-1296346-C | Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical | SANOFI AVENTIS DEUTSCHLAND (DE) | 2007-01-24 | — | — | CN | disclosed |
| US-6759412-B2 | FOR PRODUCING DRUGS USED FOR THERAPY OF CARDIOVASCULAR DISEASES, STABLE OR UNSTABLE ANGINA PECTORIS, CORONARY HEART DISEASE, PRINZMETAL ANGINA, ACUTE CORONARY SYNDROME, HEART FAILURE, MYOCARDIAL INFARCTION, STROKE, THROMBOSIS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2004-07-06 | — | — | US | disclosed |
| CN-1491208-A | Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical | ������ҽҩ�¹�����˾ | 2004-04-21 | — | — | CN | disclosed |
| JP-H03127790-A | N-(1H-TETRAZOL-5-YL)-2-ANILINO-5-PYRIMIDINECARBOXAMIDES AND SYNTHETIC INTERMEDIATE THEREFOR | MORISHITA PHARMACEUT CO LTD | 1991-05-30 | — | — | JP | disclosed |